Log In
Print this Print this

RDD 0315

  Manage Alerts
Collapse Summary General Information
Company RDD Pharma Ltd.
Molecular Target Adrenergic receptor alpha (ADRA)
Mechanism of ActionAdrenergic receptor alpha (ADRA) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard Indication Gastrointestinal (unspecified)
Indication DetailsTreat fecal incontinence in spinal cord injury patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today